
News|Articles|January 1, 2002
Meta-analysis reveals only small differences among triptans
Differences among oral selective serotonin agonists (triptans) are small but clinically relevant for the individual patient, according to a comprehensive meta-analysis.
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Growth of GLP-1 therapies has reshaped the market | PBMI 2026
2
Deborah Dempsey, Pharm.D., MBA, RPh, on 340B discounts vs. rebates | PBMI 2026
3
Navitus launches GLP-1 drug management programs
4
Judi Health, Employers Health team up to launch new PBM solution
5

















